PUBLISHER: The Business Research Company | PRODUCT CODE: 1942784
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942784
Electrical stimulation devices are compact electronic devices affixed to the skin using electrodes and worn externally by patients. They are utilized for reducing acute post-operative pain and swelling, as well as for treating chronic intractable pain. These devices emit gentle electrical pulses through the skin and are effective in addressing a variety of nerve and musculoskeletal pain disorders.
The primary types of electrical stimulation devices include deep brain stimulation devices, neuromuscular electrical stimulation devices, sacral nerve stimulation devices, spinal cord stimulation devices, and others. Deep brain stimulation devices involve a medical treatment method that employs an implanted device to deliver electrical currents to specific areas of the brain. This treatment is commonly used for managing movement disorders associated with conditions such as Parkinson's disease (PD), dystonia, essential tremors, and other neurological conditions. Electrical stimulation devices are applied across various domains, including pain management, neurological and movement disorder management, musculoskeletal disorder management, metabolism, gastrointestinal management, and more. These devices are utilized by hospitals, ambulatory surgical centers, and other healthcare facilities.
Tariffs are influencing the electrical stimulation devices market by increasing costs of imported semiconductors, electrodes, batteries, and implantable components used in spinal cord and deep brain stimulation systems. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on high-precision imported electronics, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing device prices and extending approval timelines. At the same time, they are supporting local manufacturing, domestic component sourcing, and innovation in next-generation stimulation technologies.
The electrical stimulation devices market research report is one of a series of new reports from The Business Research Company that provides electrical stimulation devices market statistics, including electrical stimulation devices industry global market size, regional shares, competitors with a electrical stimulation devices market share, detailed electrical stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the electrical stimulation devices industry. This electrical stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The electrical stimulation devices market size has grown strongly in recent years. It will grow from $8.43 billion in 2025 to $9.25 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of chronic pain disorders, rising adoption of neurostimulation therapies, expansion of minimally invasive treatment options, improved clinical outcomes from stimulation devices, growing physician awareness of neuromodulation.
The electrical stimulation devices market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing adoption of personalized neuromodulation treatments, rising investments in smart implantable devices, expansion of outpatient pain management procedures, growing focus on remote device monitoring, increasing demand for advanced neurological therapies. Major trends in the forecast period include increasing adoption of implantable neurostimulation devices, rising demand for non-invasive pain management solutions, growing integration of smart control systems, expansion of neuromodulation therapies, enhanced focus on patient-specific treatment protocols.
The rising prevalence of muscle disorders is anticipated to drive growth in the electrical stimulation devices market. Muscle disorders comprise a range of inherited genetic conditions that lead to progressive muscle weakness over time. These disorders can result in weakness or paralysis even when the nervous system remains intact. Electrical stimulation devices are designed to alleviate muscle weakness by generating controlled and comfortable muscle contractions using skin electrodes and a portable stimulator. For instance, in June 2024, the Australian Institute of Health and Welfare, an Australian government agency, estimated that around 7.3 million Australians (29%) were living with chronic musculoskeletal conditions in 2022. Among these individuals, 4.0 million (16%) reported experiencing back issues, 3.7 million (15%) were diagnosed with arthritis, and 854,000 (3.4%) were affected by osteoporosis or osteopenia. Consequently, the increasing incidence of muscle disorders is driving the growth of the electrical stimulation devices market.
Major companies operating in the electrical stimulation devices market are prioritizing the development of advanced solutions, including high-definition transcranial electrical stimulation (HD-tES) combined with wireless electroencephalography (EEG) monitoring. HD-tES is a non-invasive neuromodulation technique that employs multiple, precisely controlled small electrodes to shape electrical current and target specific cortical areas with greater spatial precision than conventional two-pad transcranial direct current stimulation (tDCS). For example, in May 2024, Soterix Medical Inc., a United States-based medical device manufacturer, introduced the MxN-GO EEG system, an integrated, wire-free HD-tES and EEG platform. The MxN-GO EEG system is designed as a lightweight, untethered headset that combines 33 stimulation channels with 32 recording channels, enabling simultaneous high-definition stimulation and real-time EEG acquisition; it features modular electrode arrays and an onboard controller that supports rapid setup and programmable multi-site waveforms. From a functional perspective, the system delivers accurate spatial targeting, synchronized stimulation and recording for research or clinical applications, and enhanced portability for use in clinical or bedside environments.
In September 2023, Amber Therapeutics Ltd., a United Kingdom-based healthcare technology company, acquired Bioinduction Limited for an undisclosed consideration. Through this acquisition, Amber Therapeutics Ltd. obtained full control over the development and manufacturing of Picostim-based hardware, enabling it to accelerate the development and commercialization of its Amber-UI neuromodulation therapy and to expand its portfolio of adaptive neurostimulation technologies. Bioinduction Limited is a United Kingdom-based medical device and technology company specializing in implantable, closed-loop neuromodulation systems.
Major companies operating in the electrical stimulation devices market are Boston Scientific Corporation, Abbott Laboratories, DJO Global Inc., BTL Corporate Inc., Nevro Corp., NeuroMetrix Inc., Zynex Inc., BioMedical Life Systems, RS Medical, Beijing Pins Medical Co. Ltd., MicroPort Scientific Corporation, Soterix Medical Inc., Medtronic plc, MYOLYN, Cyberonics Inc., Stimwave Technologies, EndoStim Inc., SPR Therapeutics, Nuvectra Corporation, ElectroCore Inc., Axonics Modulation Technologies Inc., Inspire Medical Systems Inc.
North America was the largest region in the electrical stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the electrical stimulation devices market report during the forecast period. The regions covered in the electrical stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the electrical stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The electrical stimulation devices market consists of sales of implantable electronic stimulation devices, vagus nerve stimulation (VNS) devices and transcutaneous electrical nerve stimulation (TENS) devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electrical Stimulation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses electrical stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electrical stimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrical stimulation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.